BA
REVS icon

Bivin & Associates’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bivin & Associates’s Portfolio REVS Stock Details REVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$2K Buy
110
+42
+62% +$855 ﹤0.01% 236
2022
Q1 		$1K Buy
68
+30
+79% +$633 ﹤0.01% 322
2021
Q4 		$1K Buy
+38
New +$796 ﹤0.01% 358

Other funds holding REVS

ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bivin & Associates's REVS Position: Q2 2022 in Review

Bivin & Associates increased its Columbia Research Enhanced Value ETF (REVS) stake by 62% in Q2 2022, buying an estimated $855 and bringing the position to 110 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #236.

Bivin & Associates first reported a position in REVS in Q4 2021 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold REVS as of Q2 2022.

  • Bivin & Associates held 110 shares of Columbia Research Enhanced Value ETF worth $2K as of Q2 2022.
  • Bivin & Associates bought 42 Columbia Research Enhanced Value ETF shares in Q2 2022, an estimated $855.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #236 holding.
  • Bivin & Associates first reported a position in Columbia Research Enhanced Value ETF in Q4 2021 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.